Cover Image

Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma

Saved in:

Bibliographic Details
Main Authors:	Joo Hyun Oh (Author), Dong Hyun Sinn (Author)
Format:	Book
Published:	Korean Liver Cancer Association, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
by: Jiwon Yang, et al.
Published: (2024)

Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy
by: Xu B, et al.
Published: (2023)

Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives
by: Joo Hyun Oh, et al.
Published: (2024)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020)

Second-line treatment options in hepatocellular carcinoma
by: Donatella Marino, et al.
Published: (2019)

Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma
by: Jinhuan Yang, et al.
Published: (2022)

Transformación anaplásica tardía de bocio multinodular Late anaplastic transformation Of multinodular goitre
by: Lidia Martínez Ramos
Published: (2012)

The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
by: Jihyun An, et al.
Published: (2022)

Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
by: Dong Jin Joo, et al.
Published: (2021)

Plexiform (multinodular) neurilemoma of the tongue
by: Rekha B Chaudhari
Published: (2013)

Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
by: Bo Hyun Kim, et al.
Published: (2021)

A large multinodular mass on the back
by: Ryan Gillihan, et al.
Published: (2020)

Efficacy and Safety of an mHealth App and Wearable Device in Physical Performance for Patients With Hepatocellular Carcinoma: Development and Usability Study
by: Kim, Yoon, et al.
Published: (2020)

CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF MULTINODULAR EUTHYROID GOITER
by: М.К. GULOV, et al.
Published: (2017)

Parada respiratoria secundaria a bocio multinodular
by: Mónica Ríos Prego, et al.
Published: (2016)

The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
by: Landon L. Chan, et al.
Published: (2024)

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
by: Sujin Jin, et al.
Published: (2023)

Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis
by: Manuel Lim, et al.
Published: (2024)

Transformación anaplásica tard ía de bocio multinodular
by: Lidia Martínez Ramos
Published: (2012)

Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
by: Dong-Hyun Kim
Published: (2022)

Short-term outcomes of surgical resection and radiofrequency in treatment of hepatocellular carcinoma
by: Alshimaa M.M Eid, et al.
Published: (2020)

A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics
by: Menghan Zhang, et al.
Published: (2024)

Angiogenesis in liver cirrhosis and hepatocellular carcinoma
by: Amarapurkar Anjali, et al.
Published: (2008)

Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelines
by: Soumya Jogi, et al.
Published: (2020)

Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
by: Seong Kyun Na
Published: (2022)

Diffuse infiltration of Aspergillus hyphae in the thyroid gland with multinodular goiter
by: Havva Erdem, et al.
Published: (2011)

Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
by: Byeong Geun Song, et al.
Published: (2024)

Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review
by: He ZX, et al.
Published: (2016)

Nivolumab Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
by: Yan Li, et al.
Published: (2022)

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma
by: Ying He, et al.
Published: (2023)

The Cost Effectiveness of Donafenib Compared With Sorafenib for the First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in China
by: Rui Meng, et al.
Published: (2022)

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
by: Jin Ho Shin, et al.
Published: (2015)

Tuberculosis of the thyroid presenting as multinodular goiter with hypothyroidism: A rare presentation
by: Chaudhary Abhideep, et al.
Published: (2010)

Combined Bone Mineral Density (BMD) and Monocyte-to-Lymphocyte Ratio (MLR) Predicts Recurrence and Prognosis in Hepatocellular Carcinoma Patients Following Liver Resection
by: He ZJ, et al.
Published: (2024)

Moving beyond first-line treatment options for OCD
by: Chris Paxos, PharmD, BCGP, BCPS, BCPP
Published: (2022)

Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
by: Seungchul Han, et al.
Published: (2024)

Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
by: Yuri Cho, et al.
Published: (2023)

Tislelizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China: a cost-effectiveness analysis
by: Zhiwei Zheng, et al.
Published: (2024)

Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment
by: Yudai Fujiwara, et al.
Published: (2024)

The efficacy of treatment for hepatocellular carcinoma in elderly patients
by: Han Ah Lee, et al.
Published: (2023)